Latest Capital Equipment News

Cyprium Metals has made substantial progress on its Nifty Copper Complex restart, targeting copper cathode production by September 2026 while securing A$41 million to fuel exploration and growth.

CurveBeam AI reported stable device orders but faces regulatory delays for FDA and China clearances, while securing a A$4 million investment from WEGO Orthopaedics and advancing clinical collaborations with robotic surgery systems.

CONNEQT Health’s Pulse device sales surged to a $7 million annualised run-rate despite a temporary supply hiccup, while the company manages a tight cash runway supported by new R&D loans and related-party funding.

Imricor Medical Systems advanced FDA clearances and expanded clinical trials in Q1 CY26, positioning for commercial growth despite higher operating cash outflows.

333D Ltd (ASX:T3D) reversed its prior quarter’s cash outflow to report a $71,505 positive operating cash flow for March 2026, driven by growing healthcare digital asset contracts and a strategic Bitcoin holding. The company also deployed $95,800 post-quarter to scale its healthcare-focused platform.

Compumedics maintains robust sales momentum but faces FY26 revenue timing challenges due to MEG installation delays and a cautious Somfit D rollout. The company expects solid year-on-year growth and positions for improved execution in FY27.

Freehill Mining’s aggregate materials sales surged in March, with quarterly sales up 60%, while the company prioritises mine planning and permitting for its Blanco y Negro copper-gold project.

XRF Scientific posted a 13.8% jump in March quarter revenue to $15.8 million, led by strong international sales and new product shipments. The newly operational India office marks a strategic expansion, setting the stage for further growth.

Galan Lithium has finished Phase 1 construction at its Hombre Muerto West project in Argentina and is set to begin lithium production in the first half of 2026, marking a key milestone toward becoming an ASX-listed producer.

CONNEQT Health reported a 40% revenue increase to $2.28 million for the half-year ending December 2025, driven by strong sales of its CONNEQT Pulse device and early subscription uptake. Despite narrowing its net loss by 14%, the company continues to navigate operational restructuring and funding challenges as it pivots towards a recurring revenue model.

Compumedics Limited has reported a robust half-year performance, with revenue climbing 32% to $31 million and a return to profitability, driven by strong MEG system sales and SaaS growth.

XRF Scientific has reported a record first half for December 2025, with revenue and profits rising on the back of strong mining demand and international expansion.